Agate Pass Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
|
|||||
|
2026
Q1 | $293K | Sell |
|
|||||
|
2025
Q4 | $419K | Sell |
|
|||||
|
2025
Q3 | $489K | Buy |
|
|||||
|
2025
Q2 | $571K | Buy |
|
|||||
|
2025
Q1 | $529K | Sell |
|
|||||
|
2024
Q4 | $690K | Sell |
|
|||||
|
2024
Q3 | $1.52M | Sell |
|
|||||
|
2024
Q2 | $1.89M | Sell |
|
|||||
|
2024
Q1 | $1.77M | Sell |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $1.19M | Sell |
|
|||||
|
2023
Q1 | $1.2M | Sell |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $764K | Sell |
|
|||||
|
2022
Q2 | $875K | Buy |
|
|||||
|
2022
Q1 | $868K | Buy |
|
|||||
|
2021
Q4 | $825K | Buy |
|